Clinical reports on MDMA suggest the drug temporarily shuts off the amygdala, which is why it is being studied for the treatment of PTSD. The hosts discuss the history of the drug in Silicon Valley and its effects on social behavior, contrasting it with the negative side effects of SSRIs and stimulants.












